Blood Clot clinical trials at UC Davis
3 research studies open to eligible people
A Registry Study: Global Anticoagulant Registry for Venous Thromboembolic Events (blood clot in a vein)
“We invite you to take part in a research study because you have recently been diagnosed with a blood clot in your leg or chest.”
open to eligible people ages 18-99
The protocol is a large registry to describe acute, sub-acute and extended duration of anticoagulation management, clinical and economic duration of anticoagulation management, clinical and economic outcomes in patients with treated acute VTE (DVT and PE) in the real-world setting. Main objectives are to clarify the: - treatment related details for acute VTE (either conventional anticoagulation therapy, treatment with a direct oral anti-coagulant or other modalities of treatment) - Rate of early and late symptomatic VTE recurrence - Rate and nature of complications of VTE including post thrombotic syndrome and chronic thromboembolic pulmonary hypertension - Rate of bleeding complications - Rate of all-cause mortality at six months
Muscle Shoals, Alabama
open to eligible people ages up to 17 years
To assess the safety and descriptive efficacy of apixaban in pediatric subjects requiring anticoagulation for the treatment of a VTE.
Sacramento, California and other locations
A Study of Two Different Ablation Methods (Transseptal vs Retrograde) to Reduce Systemic Emboli (blood clots)
open to eligible people ages 18 years and up
This study is a prospective, multicenter, randomized (1:1) controlled comparative effectiveness trial of a transseptal approach to left ventricular ablation compared to a retrograde aortic approach to prevent cerebral emboli and neurocognitive decline in adults with ventricular tachycardia (VT) and/or premature ventricular contractions (PVCs).
San Francisco, California